REQUEST A DEMO
Total
USD $0.00
Search more companies

Cong Ty Co Phan Duoc Pham Imexpharm (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Cong Ty Co Phan Duoc Pham Imexpharm Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Imexpharm Corporation (IMP) primarily manufactures, exports and imports pharmaceutical products, materials, medical facilities. IMP owns two main factories located in headquarter of Dong Thap province, according to GMP-ASEAN standard, and the system of warehouse according to GLP-ASEAN standard. The main products include painkiller, antipyretic, antibiotic, vitamin, nutrition food. IMP was founded in 2006 and based in Dong Thap, Mekong Delta, Vietnam. The company is listed on Ho Chi Minh Stock Exchange under the Main Market.

Headquarters
No 4, 30/4 Street, Ward 1, Cao Lanh City
Dong Thap; Mekong River Delta; Postal Code: 87

Contact Details: Purchase the Cong Ty Co Phan Duoc Pham Imexpharm report to view the information.

Website: http://www.imexpharm.com.vn

Basic Information
Total Employees:
Purchase the Cong Ty Co Phan Duoc Pham Imexpharm report to view the information.
Outstanding Shares:
Purchase the Cong Ty Co Phan Duoc Pham Imexpharm report to view the information.
Registered Capital:
Purchase the Cong Ty Co Phan Duoc Pham Imexpharm report to view the information.
Financial Auditors:
Purchase the Cong Ty Co Phan Duoc Pham Imexpharm report to view the information.
Incorporation Date:
December 04, 2006
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Ownership Details
Purchase this report to view the information.
47.67%
Purchase this report to view the information.
9.74%
Subsidiaries
Công ty Cổ phần Hiệp Thành
58%
Công ty Cổ phần đầu tư phát triển đô thị Tân tạo
40%
Công ty Cổ phần Hiệp Phú
35%
Company Performance
Financial values in the chart are available after Cong Ty Co Phan Duoc Pham Imexpharm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
21.31%
Total operating revenue
21.31%
Operating profit (EBIT)
28.98%
EBITDA
29.93%
Net Profit (Loss) for the Period
34.01%
Total assets
5.08%
Total equity
10.04%
Operating Profit Margin (ROS)
1.14%
Net Profit Margin
1.42%
Return on Equity (ROE)
2.57%
Debt to Equity Ratio
-2.64%
Quick Ratio
-0.1%
Cash Ratio
-0.12%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?